Company Data
Immix Biopharma Inc.
Ticker
IMMX
Current Price
$2.04 -0.49%
Market Cap
$30.7M
Price Target
Refer to Report
Volume
67.7K
52wk Range
$0.68 - $3.35
Overview
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation. Its product candidate drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME.